ANI Pharmaceuticals, Inc. - relatórios financeiros trimestrais (NASDAQ:ANIP) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Market Capitalization 1.7151 B
Employee 970
Founded 2001
CEO N/A
Website www.anipharmaceuticals.com
Headquarter Delaware, United States
FIGI BBG000KK1L04
Industry Fabricantes de medicamentos - especializados e genéricos

Receita total

Lucro líquido

Lucro básico por ação

Dívida total

Fluxo de caixa livre

Caixa e equivalentes de caixa

1.72 B Capitalização de mercado

Índice preço/lucro

23.78

Índice preço/fluxo de caixa

1.9

Notícias

CGON Stock Up 60.8% in Six Months: Here's What You Need to Know

KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug

RVMD Stock Rallies 41% on Positive Phase III Pancreatic Cancer Data

IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results

ANI Pharmaceuticals Stock: Undervalued Cortrophin Drives Rare Disease Growth (NASDAQ:ANIP)

Zacks.com featured highlights include Intuit, ANI Pharmaceuticals and Gaming and Leisure Properties

Is American Well (AMWL) Outperforming Other Medical Stocks This Year?

Insmed Ends Brinsupri Development in Skin Disease Post Study Failure

ANI Pharmaceuticals lança comprimidos genéricos de mononitrato de isossorbida

ANI Pharmaceuticals Stock: Worthy Of A Position (NASDAQ:ANIP)

Kodiak Q4 Loss Wider Than Expected, Pipeline Development in Focus

AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD